[1] BRODEUR GM.Neuroblastoma:biological insights into a clinical enigma[J].Nature Reviews Cancer,2003,3(3):203-216.
[2] COHN SL,PEARSON AD,LONDON WB,et al.The International Neuroblastoma Risk Group (INRG) classification system:an INRG Task Force report[J].Journal of Clinical Oncology,2009,27(2):289-297.
[3] PINTO NR,APPLEBAUM MA,VOLCHENBOUM SL,et al.Advances in risk classification and treatment strategies for neuroblastoma[J].Journal of Clinical Oncology,2015,33(27):3008-317.
[4] PARK JA,CHEUNG NV.Targets and antibody formats for immunotherapy of neuroblastoma[J].Journal of Clinical Oncology,2020,38(16):1836-1848.
[5] SLACK FJ,CHINNAIYAN AM.The role of non-coding RNAs in oncology[J].Cell,2019,179(5):1033-1055.
[6] PATOP IL,WST S,KADENER S.Past,present,and future of circRNAs[J].The EMBO Journal,2019,38(16):e100836.
[7] SU H,TAO T,YANG Z,et al.Circular RNA cTFRC acts as the sponge of MicroRNA-107 to promote bladder carcinoma progression[J].Molecular Cancer,2019,18(1):27.
[8] WEI Y,LU C,ZHOU P,et al.EIF4A3-induced circular RNA ASAP1 promotes tumorigenesis and temozolomide resistance of glioblastoma via NRAS/MEK1/ERK1-2 signaling[J].Neuro-oncology,2021,23(4):611-624.
[9] LI H,YANG F,HU A,et al.Therapeutic targeting of circ-CUX1/EWSR1/MAZ axis inhibits glycolysis and neuroblastoma progression[J].EMBO Molecular Medicine,2019,11(12):e10835.
[10] 万江洋,陆圣威,甄林林.环状RNA在乳腺癌中的研究进展[J].现代肿瘤医学,2020,28(13):2358-2361.
WAN JY,LU SW,ZHEN LL.Research progress of circular RNA in breast cancer[J].Modern Oncology,2020,28(13):2358-2361.
[11] GUARNERIO J,BEZZI M,JEONG JC,et al.Oncogenic role of fusion-circRNAs derived from cancer-associated chromosomal translocations[J].Cell,2016,165(2):289-302.
[12] KRISTENSEN LS,ANDERSEN MS,STAGSTED LVW,et al.The biogenesis,biology and characterization of circular RNAs[J].Nature Reviews Genetics,2019,20(11):675-691.
[13] JECK WR,SORRENTINO JA,WANG K,et al.Circular RNAs are abundant,conserved,and associated with ALU repeats[J].RNA (New York,NY),2013,19(2):141-157.
[14] LIANG D,WILUSZ JE.Short intronic repeat sequences facilitate circular RNA production[J].Genes & Development,2014,28(20):2233-2247.
[15] ZHANG XO,WANG HB,ZHANG Y,et al.Complementary sequence-mediated exon circularization[J].Cell,2014,159(1):134-147.
[16] VICENS Q,WESTHOF E.Biogenesis of circular RNAs[J].Cell,2014,159(1):13-14.
[17] WANG PL,BAO Y,YEE MC,et al.Circular RNA is expressed across the eukaryotic tree of life[J].PLoS One,2014,9(6):e90859.
[18] SALZMAN J,CHEN RE,OLSEN MN,et al.Cell-type specific features of circular RNA expression[J].PLoS Genetics,2013,9(9):e1003777.
[19] GUO JU,AGARWAL V,GUO H,et al.Expanded identification and characterization of mammalian circular RNAs[J].Genome Biology,2014,15(7):409.
[20] HANSEN TB,JENSEN TI,CLAUSEN BH,et al.Natural RNA circles function as efficient microRNA sponges[J].Nature,2013,495(7441):384-388.
[21] ABDELMOHSEN K,PANDA AC,MUNK R,et al.Identification of HuR target circular RNAs uncovers suppression of PABPN1 translation by CircPABPN1[J].RNA Biology,2017,14(3):361-369.
[22] ZHANG Y,ZHANG XO,CHEN T,et al.Circular intronic long noncoding RNAs[J].Molecular Cell,2013,51(6):792-806.
[23] LI Z,HUANG C,BAO C,et al.Exon-intron circular RNAs regulate transcription in the nucleus[J].Nature Structural & Molecular Biology,2015,22(3):256-264.
[24] ASHWAL-FLUSS R,MEYER M,PAMUDURTI NR,et al.circRNA biogenesis competes with pre-mRNA splicing[J].Molecular Cell,2014,56(1):55-66.
[25] MAHMOUDI E,KILTSCHEWSKIJ D,FITZSIMMONS C,et al.Depolarization-associated CircRNA regulate neural gene expression and in some cases may function as templates for translation[J].Cells,2019,9(1):25.
[26] ZHAO J,LEE EE,KIM J,et al.Transforming activity of an oncoprotein-encoding circular RNA from human papillomavirus[J].Nature Communications,2019,10(1):2300.
[27] ZHANG L,ZHOU H,LI J,et al.Comprehensive characterization of circular RNAs in neuroblastoma cell lines[J].Technology in Cancer Research & Treatment,2020,19:1533033820957622.
[28] LIN W,WANG Z,WANG J,et al.circRNA-TBC1D4,circRNA-NAALAD2 and circRNA-TGFBR3:selected key circRNAs in neuroblastoma and their associations with clinical features[J].Cancer Management and Research,2021,13:4271-4281.
[29] LIN X,LO HC,WONG DT,et al.Noncoding RNAs in human saliva as potential disease biomarkers[J].Front Genet,2015,6:175.
[30] MEMCZAK S,PAPAVASILEIOU P,PETERS O,et al.Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood[J].PLoS One,2015,10(10):e0141214.
[31] CHEN Y,LIN L,HU X,et al.Silencing of circular RNA circPDE5A suppresses neuroblastoma progression by targeting the miR-362-5p/NOL4L axis[J].The International Journal of Neuroscience,2021:1-11.
[32] CHEN Y,YANG F,FANG E,et al.Circular RNA circAGO2 drives cancer progression through facilitating HuR-repressed functions of AGO2-miRNA complexes[J].Cell Death and Differentiation,2019,26(7):1346-1364.
[33] YANG J,YU L,YAN J,et al.Circular RNA DGKB promotes the progression of neuroblastoma by targeting miR-873/GLI1 axis[J].Frontiers in Oncology,2020,10:1104.
[34] FANG Y,YAO Y,MAO K,et al.Circ_0132817 facilitates cell proliferation,migration,invasion and glycolysis by regulating the miR-432-5p/NOL4L axis in neuroblastoma[J].Experimental Brain Research,2021,239(6):1841-1852.
[35] YANG Y,PAN H,CHEN J,et al.CircKIF2A contributes to cell proliferation,migration,invasion and glycolysis in human neuroblastoma by regulating miR-129-5p/PLK4 axis[J].Molecular and Cellular Biochemistry,2021,476(6):2513-2525.
[36] WANG Y,NIU Q,DAI J,et al.circCUX1 promotes neuroblastoma progression and glycolysis by regulating the miR-338-3p/PHF20 axis[J].General Physiology and Biophysics,2021,40(1):17-29.
[37] ZHANG X,ZHANG J,LIU Q,et al.Circ-CUX1 accelerates the progression of neuroblastoma via miR-16-5p/DMRT2 axis[J].Neurochemical Research,2020,45(12):2840-2855.